Cargando…
Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones
BACKGROUND: CRISPR/Cas9 editing systems are currently used to generate mutations in a particular gene to mimic a genetic disorder in vitro. Such “disease in a dish” models based on human pluripotent stem cells (hPSCs) offer the opportunity to have access to virtually all cell types of the human body...
Autores principales: | Frank, Elie, Cailleret, Michel, Nelep, Constantin, Fragner, Pascal, Polentes, Jérome, Herardot, Elise, El Kassar, Lina, Giraud-Triboult, Karine, Monville, Christelle, Ben M’Barek, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142500/ https://www.ncbi.nlm.nih.gov/pubmed/37106426 http://dx.doi.org/10.1186/s13287-023-03327-2 |
Ejemplares similares
-
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells
por: Rossiaud, Lucille, et al.
Publicado: (2023) -
The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles
por: Jarrige, Margot, et al.
Publicado: (2021) -
Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering
por: Ben M'Barek, Karim, et al.
Publicado: (2019) -
Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions
por: Regent, Florian, et al.
Publicado: (2019) -
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis
por: Mérien, Antoine, et al.
Publicado: (2021)